KR100337005B1 - The composites of raw-type tea fortified the function of reducing cholesterol and thrombi - Google Patents
The composites of raw-type tea fortified the function of reducing cholesterol and thrombi Download PDFInfo
- Publication number
- KR100337005B1 KR100337005B1 KR1020000070027A KR20000070027A KR100337005B1 KR 100337005 B1 KR100337005 B1 KR 100337005B1 KR 1020000070027 A KR1020000070027 A KR 1020000070027A KR 20000070027 A KR20000070027 A KR 20000070027A KR 100337005 B1 KR100337005 B1 KR 100337005B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- germinated
- cholesterol
- function
- tea
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims abstract description 54
- 235000012000 cholesterol Nutrition 0.000 title claims abstract description 25
- 241001122767 Theaceae Species 0.000 title 1
- 239000002131 composite material Substances 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 30
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 230000001850 reproductive effect Effects 0.000 claims abstract description 18
- 229940086319 nattokinase Drugs 0.000 claims abstract description 17
- 108010073682 nattokinase Proteins 0.000 claims abstract description 17
- 208000007536 Thrombosis Diseases 0.000 claims abstract description 16
- 229940026314 red yeast rice Drugs 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 3
- 230000035784 germination Effects 0.000 claims description 12
- 241001474374 Blennius Species 0.000 claims description 11
- 235000021329 brown rice Nutrition 0.000 claims description 11
- 240000007124 Brassica oleracea Species 0.000 claims description 8
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 8
- 240000000599 Lentinula edodes Species 0.000 claims description 8
- 240000007594 Oryza sativa Species 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 240000005979 Hordeum vulgare Species 0.000 claims description 7
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 5
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 244000088415 Raphanus sativus Species 0.000 claims description 5
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- 235000007215 black sesame Nutrition 0.000 claims description 5
- 235000005822 corn Nutrition 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 229940109850 royal jelly Drugs 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 4
- 240000001417 Vigna umbellata Species 0.000 claims description 4
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 3
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 3
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 240000006891 Artemisia vulgaris Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 229940088598 enzyme Drugs 0.000 abstract description 8
- 230000015572 biosynthetic process Effects 0.000 abstract description 7
- 235000013339 cereals Nutrition 0.000 abstract description 5
- 230000002537 thrombolytic effect Effects 0.000 abstract description 5
- 235000013311 vegetables Nutrition 0.000 abstract description 5
- 239000003146 anticoagulant agent Substances 0.000 abstract description 4
- 238000000227 grinding Methods 0.000 abstract description 3
- 235000002789 Panax ginseng Nutrition 0.000 abstract description 2
- 230000006735 deficit Effects 0.000 abstract description 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 22
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 20
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 11
- 239000011575 calcium Substances 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 235000001465 calcium Nutrition 0.000 description 11
- 229910052742 iron Inorganic materials 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 208000017169 kidney disease Diseases 0.000 description 7
- 229910052700 potassium Inorganic materials 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 208000019622 heart disease Diseases 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 229940057059 monascus purpureus Drugs 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 235000014786 phosphorus Nutrition 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- 241000269837 Artemisia dubia Species 0.000 description 4
- 229930003270 Vitamin B Natural products 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000001784 detoxification Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 235000001715 Lentinula edodes Nutrition 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 235000007189 Oryza longistaminata Nutrition 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 240000006394 Sorghum bicolor Species 0.000 description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 235000010445 lecithin Nutrition 0.000 description 3
- 229940067606 lecithin Drugs 0.000 description 3
- 239000000787 lecithin Substances 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 235000007686 potassium Nutrition 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 238000008214 LDL Cholesterol Methods 0.000 description 2
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 229960000103 thrombolytic agent Drugs 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000006914 Aspalathus linearis Species 0.000 description 1
- 235000012984 Aspalathus linearis Nutrition 0.000 description 1
- -1 B 2 Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 235000015220 hamburgers Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 108010073863 saruplase Proteins 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000022934 urinary frequency Diseases 0.000 description 1
- 230000036318 urination frequency Effects 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 콜레스테롤 및 혈전 저하 기능이 강화된 생식 타입의 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition of the reproduction type with enhanced cholesterol and thrombus lowering function.
본 발명은 홍국, 나토키나제 등이 함유된 콜레스테롤 및 혈전 저하 기능이 강화된 차(茶) 조성물에 관한 것으로서, 더욱 상세하게는 곡식류와 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 섭취하는 생식 타입의 차에 콜레스테롤 생합성을 억제하는 홍국과 혈전 용해 기능이 있는 효소인 나토키나제를 첨가하여 혈액 순환 장해 개선 효과를 강화한 생식 타입 차 조성물에 관한 것이다.The present invention relates to a tea composition with enhanced cholesterol and thrombus lowering function containing red yeast rice, nattokinase, and the like, and more particularly, raw foods which are ingested by drying after powdering without mixing grains and vegetables. The present invention relates to a reproductive type tea composition in which red ginseng that inhibits cholesterol biosynthesis and nattokinase, an enzyme having a thrombolytic function, is added to a type of tea, thereby enhancing blood circulation impairment.
Description
본 발명은 콜레스테롤 및 혈전 저하 기능이 강화된 생식 타입의 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition of the reproduction type with enhanced cholesterol and thrombus lowering function.
본 발명은 곡식류, 채소류, 해조류, 버섯류 등을 열에 익히지 않고 건조 분말화한 후 생분말 상태로 물이나 음료수에 타서 음용하는 생식 타입의 차(茶)에 홍국 및 나토키나제 등을 첨가하여 생식 타입 차 조성물의 콜레스테롤 및 혈전 저하 기능을 강화한 것이다.The present invention is a reproductive type tea by adding grains, vegetables, algae, mushrooms, etc. to the raw type tea (tea) to drink in water or drink in a raw powder state after drying and powdering without heating It is to strengthen the cholesterol and thrombus lowering function of the composition.
생식이란 열을 가하지 않은 식품으로서 일반적으로 곡식류, 채소류, 해조류 및 버섯류 등을 열에 익히지 않고 건조 분말화한 후 생분말 상태로 물이나 음료수에 타서 먹는 것을 말하며 식품을 익혀서 먹는 화식보다 효소, 비타민이 많으며 에너지 효율이 높은 장점이 있다.Raw foods are foods that do not apply heat. In general, grains, vegetables, algae, and mushrooms are dried and powdered without being heated, and they are eaten in water or drink as raw powder.They contain more enzymes and vitamins than cooked foods. It has the advantage of high energy efficiency.
술, 담배 등 인체에 해로운 기호 식품과 육류, 인스턴트 식품의 과식 등은 노폐물을 많이 만들어내기 때문에 혈액 순환의 장애를 가져와 심장 질환을 일으키는 원인이 된다. 또 오장 육부의 기능을 급격히 약화시키면서 간장병, 폐질환 등을 유발하기도 한다.Overeating foods, meats, and instant foods that are harmful to the human body, such as alcohol and cigarettes, produce a lot of waste products, resulting in impaired blood circulation and heart disease. In addition, the function of the five intestines rapidly abruptly lead to liver disease and lung diseases.
이럴 때 생식을 하면 다량의 효소와 엽록소를 섭취할 수 있게 되므로 노폐물이 차차 빠져 나오게 된다. 엽록소는 식물의 피라고 할 수 있는데, 인간의 혈액과 유사한 구조로 되어 있어 섭취하면 그대로 혈액으로 바뀐다. 푸른 채소에 많이 들어 있고 항암 효과, 조혈 작용, 해독 작용을 하지만 익혀서 섭취하게 되면 많이 파괴되고 칼슘과 결합해 결석의 원인이 되기도 한다. 이와 같이 노폐물이 빠져나가면 인체는 스스로 정화하는 능력을 회복하게 되어 건강을 되찾을 수 있다. 생식을 하는 사람들의 경우 음식을 익혀 먹는 화식을 하는 사람들에 비해 각종 질병 발생률이 낮다는 연구 결과가 나와 있다.If you reproduce this way, you will be able to consume large amounts of enzymes and chlorophyll, so waste will gradually come out. Chlorophyll is the blood of a plant, which is similar in structure to human blood. Green vegetables are contained in a lot of anti-cancer effect, hematopoietic, detoxification effect, but when ingested and eaten a lot is destroyed and combined with calcium can cause stones. In this way, when waste is released, the body recovers its ability to purify itself and can regain health. Studies have shown that people who reproduce have lower rates of disease than cookers who eat cooked food.
또한 생식을 하면 신진 대사가 활발해져서 세포 재생이 빨라지고 노화가 지연되며, 인체의 독소가 배설되고 혈액 순환이 촉진되어 피부가 고와질 뿐만 아니라 탄력이 생긴다.In addition, reproductive activity is accelerated by the regeneration of cells, the aging delay is delayed, the toxins of the human body is excreted, blood circulation is promoted, the skin is not only hardened, but also elastic.
이와 같이 혈액 속의 노폐물을 제거하고 우리 몸 구석구석까지 깨끗한 혈액을 보내면 세포의 기능이 활발해지고 따라서 머리가 맑아지며 집중력, 지구력 등이 향상된다.In this way, if you remove the waste in the blood and send clean blood to every corner of our body, the function of the cell becomes active, thus clearing the head and improving the concentration and endurance.
그러나 대다수의 사람들은 인스턴트 음식, 햄버거 피자 등과 같은 서양식 식문화 및 고콜레스테롤식에 많이 노출되어 있어 다량의 콜레스테롤을 섭취하게 되면 인체의 콜레스테롤 대사 균형 파괴로 콜레스테롤이 핏속에 증가하게 되고, 이에 따라 혈액의 점도가 증가하게 되므로 여러 가지 순환 기계 질환을 유발하게 된다.However, most people are exposed to Western foods such as instant foods, hamburger pizzas, and high-cholesterol foods, and eating large amounts of cholesterol increases cholesterol in the blood due to the breakdown of the body's cholesterol metabolism balance. Since the increase will cause a variety of circulatory diseases.
즉, 고점도의 혈액을 펌프질해야 하는 심장은 너무 혹사당하여 병이 생기고, 고점도 때문에 각 조직과 기관에 유입되는 혈액의 양은 현저히 줄게 되어 영양 결핍 상태가 되며 더 나아가서는 콜레스테롤이 혈관 내에 쌓여 혈관이 좁아짐으로써 동맥 경화, 심장 질환, 고혈압, 뇌졸중, 협심증, 심부전과 같은 순환기계 질환을 일으키게 된다.In other words, the heart that needs to pump high viscosity blood is so overly ill that the amount of blood that enters the tissues and organs is significantly reduced due to the high viscosity, which leads to nutritional deficiency. It causes circulatory diseases such as atherosclerosis, heart disease, high blood pressure, stroke, angina pectoris and heart failure.
또 혈관 내의 혈액이 응고되어 생기는 혈전은 혈액 점도 증가의 원인도 되어 고콜레스테롤과 같은 여러 가지 순환기계 질환을 일으키고 특히 노인성 치매와 중풍의 원인이 되는 등 큰 사회문제까지 야기시키고 있는 실정이다.In addition, blood clots caused by coagulation of blood vessels may cause an increase in blood viscosity, causing various circulatory diseases such as high cholesterol, and particularly causing social problems such as senile dementia and stroke.
그러나 시중에 시판되고 있는 혈액 순환 촉진제는 콜레스테롤을 억제하는 기능의 제품이기 때문에 혈전증에 의한 혈액 순환 불량은 효과가 없었으며, 또한 생식 타입의 차 조성물만을 섭취하는 것으로는 콜레스테롤을 감소시키고 혈액 순환을 개선시키는 효과가 미흡한 면이 있었다.However, since the commercially available blood circulation promoter is a product that suppresses cholesterol, poor blood circulation due to thrombosis was not effective, and ingesting only a reproductive type tea composition reduced cholesterol and improved blood circulation. There was an insufficient effect to let.
본 발명은 상기의 사항들을 고려하여 안출한 것으로서, 본 발명의 목적은 생식 타입의 차 조성물에 콜레스테롤 저하 기능이 있는 '홍국'과 혈관 내 혈액이 응고되어 생기는 혈전을 용해시키는 '나토키나제'를 첨가함으로써 고콜레스테롤증과 혈전 증가로 생기는 혈액의 점도 증가와 혈전증을 예방, 치료할 수 있는 기능을 강화시킨 생식 타입의 차 조성물을 제공하는 데 있다.The present invention has been devised in consideration of the above matters, and an object of the present invention is to add 'hongguk' having cholesterol lowering function and 'natokinase', which dissolves blood clots caused by blood coagulation in blood vessels. Therefore, the present invention provides a reproductive type tea composition in which a function of preventing and treating an increase in the viscosity of blood and thrombosis caused by hypercholesterolemia and an increase in thrombosis is provided.
이와 같은 목적을 달성하기 위하여 본 발명에 따른 콜레스테롤 및 혈전 저하기능이 강화된 생식 타입의 차(茶) 조성물은 곡식류와 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 섭취하는 생식 타입의 차에 콜레스테롤 생합성을 억제하는 홍국과 혈전 용해 기능이 있는 효소인 나토키나제를 첨가하여 혈액 순환 장해 개선 효과를 강화한 생식 타입 차 조성물에 관한 것이다.In order to achieve the above object, the reproductive type tea composition with enhanced cholesterol and thrombus lowering function according to the present invention is dried and powdered without ripening grains and vegetables, and then ingested in water for reproductive type tea. The present invention relates to a reproductive type tea composition in which red ginseng, which inhibits cholesterol biosynthesis, and nattokinase, an enzyme having a thrombolytic function, are added to enhance blood circulation impairment.
이하 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 콜레스테롤 및 혈전 저하 기능이 강화된 생식 타입의 차 조성물은 발아 현미 66.2∼84.5중량%, 발아 보리 1.0∼10.0중량%, 발아 수수 0.1∼0.7중량%, 발아 율무 0.1∼0.7중량%, 발아 검정콩 0.2∼0.8중량%, 발아 검정깨 0.3∼0.8중량%, 발아 옥수수 2.5∼5.0중량%, 발아 차조 1.0∼4.0중량%, 표고 버섯 0.05∼0.35중량%, 석이 버섯 0.2∼0.9중량%, 미강 0.2∼0.8중량%, 케일 0.3∼0.8중량%, 다시마 0.1∼0.6중량%, 김 0.1∼0.6중량%, 미역 0.1∼0.6중량%, 당근 0.3∼0.8중량%, 쑥 0.05∼0.35중량%, 솔잎 0.1∼0.5중량%, 무 0.1∼0.5중량% 각각을 익히지 않고 생으로 건조하여 분말로 한 것과 홍국 0.5∼3.0중량%, 나토키나제 0.05∼2.0중량%, 로얄 젤리 0.1∼0.5중량%, 젖산 효모 0.3∼0.6중량%, 스테비오 사이드 0.01∼0.03중량%로 구성되는 것을 특징으로 한다.Reproductive type tea composition with enhanced cholesterol and thrombus lowering function according to the present invention is 66.2-84.5% by weight of germinated brown rice, 1.0-10.0% by weight of germinated barley, 0.1-0.7% by weight of germination, 0.1-0.7% by weight of germination rate, Germinated black soybean 0.2-0.8 wt%, germinated black sesame seed 0.3-0.8 wt%, germinated corn 2.5-5.0 wt%, germinated green tea 1.0-4.0 wt%, shiitake mushroom 0.05-0.35 wt%, shiitake mushroom 0.2-0.9 wt%, rice bran 0.2-0.8 wt%, Kale 0.3-0.8 wt%, Kelp 0.1-0.6 wt%, Seaweed 0.1-0.6 wt%, Seaweed 0.1-0.6 wt%, Carrot 0.3-0.8 wt%, Mugwort 0.05-0.35 wt%, Pine needle 0.1 -0.5% by weight, 0.1-0.5% by weight of radish, dried, raw without powdering, 0.5-3.0% by weight of red yeast rice, 0.05-2.0% by weight of nattokinase, 0.1-0.5% by weight of royal jelly, 0.3-0.6 by lactic acid yeast It is characterized by consisting of the weight%, 0.01 to 0.03% by weight stevioside.
또한 상기 조성물에 발아 팥 1.0∼10.0중량%, 명일엽 1.0∼10.0중량%, 메밀 0.3∼0.9중량%, 양배추 0.1∼0.5중량%, 각각을 익히지 않고 생으로 건조하여 분말로 한 것을 더욱 첨가하여 그 효능을 강화시킬 수 있다.In addition, to the composition, 1.0-10.0 wt% of germinated red beans, 1.0-10.0 wt% of light days, 0.3-0.9 wt% of buckwheat, 0.1-0.5 wt% of cabbage, each of which is dried and raw without being cooked to powder, further improves its efficacy. You can strengthen it.
홍국은 쌀을 Monascus 효모로 발효시켜 만든 것으로, 균사가 선홍색의 붉은 곰팡이를 이용하여 제조함에 따라 붉은색을 띠는 것에서 홍국이라 불리우며 중국에서는 약 1000년 전부터 술, 식품 보존제, 천연색소, 약 등으로 사용되어 왔다.Hongguk is made by fermenting rice with Monascus yeast. It is called red yeast because it is made from myrtle red mold and called red yeast rice. In China, it is known as liquor, food preservative, natural pigment, medicine, etc. Has been used.
홍국이 산생하는 색소가 방부 기능을 갖고 있다고 「본초강목」에 기술되어 있고, 홍국 내에 함유되어 있는 Monacolin-K 또는 Mevinolin (HMG-CoA Reductase inhibitor)는 간장에서 합성되는 콜레스테롤을 저하시키는 기능이 있는 것으로 밝혀졌고 0.001∼0.005㎍/㎖의 낮은 농도로서도 콜레스테롤 합성을 저하시키는 것으로 나타났다. 따라서 홍국은 콜레스테롤의 생합성을 억제하는 대사물질을 생산함으로써 동맥경화와 심장병의 원인이 되는 혈중 중성지질과 LDL-콜레스테롤 수치를 저하시키며, 불포화지방산을 함유하고 있으므로 몸에 이로운 HDL-콜레스테롤 수치를 증가시킨다는 사실이 밝혀져 미국, 유럽, 일본 등에서 식품 첨가제, 건강 보조 식품 등으로 널리 사용되고 있다.The pigment produced by red yeast rice has an antiseptic function, and it is described in the herbal tree, and Monacolin-K or Mevinolin (HMG-CoA Reductase inhibitor) contained in red yeast rice has a function of lowering cholesterol synthesized in the liver. It has been found that even low concentrations of 0.001 to 0.005 μg / ml lower cholesterol synthesis. Therefore, red yeast rice reduces metabolic substances that inhibit the biosynthesis of cholesterol, which lowers blood triglycerides and LDL-cholesterol levels, which cause atherosclerosis and heart disease, and because they contain unsaturated fatty acids, increase the level of beneficial HDL-cholesterol. As it turns out, it is widely used as food additives and health supplements in the United States, Europe, and Japan.
참고로 홍국에 의한 혈중 콜레스테롤 저하 효과를 표 1에 나타내었다.For reference, the blood cholesterol lowering effect of red yeast rice is shown in Table 1.
이와 같이 홍국은 몸에 해로운 LDL 콜레스테롤은 평균 25% 이상 낮추고, 몸에 이로운 HDL 콜레스테롤은 평균 15% 이상 상승시키는 효과를 나타내었다.As a result, red yeast lowers the harmful LDL cholesterol by 25% or more and increases the beneficial HDL cholesterol by 15% or more.
홍국의 1일 권장 섭취량은 1.2g인데, 생식 타입의 차 조성물은 통상 1일 2회, 1회 40g 정도씩을 섭취하게 되므로 생식 타입 차 조성물을 1일 80g 섭취하는 것을 기준으로 할 때 0.5중량% 이하로 첨가하면 효과가 미약하며 3.0중량% 이상 첨가는 원가 상승을 유발하므로 상기 범위로 첨가하지만 1.5%를 첨가하는 것이 바람직하다.The recommended daily intake of red yeast rice is 1.2g, but the reproductive type tea composition is usually ingested by 40g once a day and twice a day, so 0.5kg% or less based on the intake of 80g per day of the reproductive type tea composition If the addition is insignificant, the effect is insignificant, and the addition of more than 3.0% by weight causes an increase in cost, but it is preferably added in the above range, but preferably 1.5% is added.
나토키나제는 대두에는 들어있지 않지만 콩을 발효시킬 때 미생물(나토균)이 대두의 영양 성분을 섭취, 생육하면서 만들어 내는 혈전 용해 효소이다. 나토키나제는 비타민 B군, 비타민 K 및 많은 양의 SOD 물질을 함유하고 있으며 열 안전성이 높은 효소로서 65℃에서 30분간 가열하여도 활성 감소율이 약 2%에 불과하다.Natokinase is a thrombolytic enzyme that is not found in soybeans, but is produced by microorganisms (nato bacteria) when they ferment soybeans. Nattokinase contains vitamin B group, vitamin K, and a large amount of SOD, and is an enzyme with high thermal stability, and the activity reduction rate is only about 2% even after heating at 65 ° C. for 30 minutes.
나토키나제는 직접적이고 강력한 혈전 분해 능력과 pro-urokinase 활성화 능력을 갖고 있으며 경구 섭취에 의해서도 효과가 있는 것으로 알려지고 있다.Natokinase has direct and potent thrombolytic activity and pro-urokinase activation and is known to be effective by oral ingestion.
또한 병원에서 자주 사용되는 혈전 용해제인 유로키나제와 비교할 때 시판 나토 1g당 유로키나제 1,600IU에 상응하며 부작용도 없으며, 병원에서 사용하는 혈전 용해제는 혈액에 들어가서 작용하는 시간이 4∼20분으로 극히 짧으나 나토키나제는 4∼8시간으로 장시간동안 효과가 지속된다. 그리고 콜레스테롤을 씻어내리는 레시틴이나 혈액을 잘 흐르게 하는 리놀산도 함유되어 있어 콜레스테롤을 낮추는 작용을 한다.In addition, compared to Eurokinase, a thrombolytic agent frequently used in hospitals, it corresponds to 1,600 IU of urokinase per gram of marketed natto and has no side effects. The thrombolytic agent used in hospitals is extremely short, with 4 to 20 minutes of action in the blood. The effect lasts for a long time with 4-8 hours. It also contains lecithin, which washes off cholesterol, and linoleic acid, which helps the blood flow better.
이와 같은 나토키나제의 1일 권장 섭취량은 1일 100∼200㎎이므로 생식 타입 차 조성물 80g(1회 40g씩 1일 2회 섭취)을 기준으로 할 때 0.125∼0.25중량%를 첨가해야 하지만 여러 조성물을 함께 섭취함에 따라 상승 효과가 있으므로 0.05중량% 이상 첨가하지만 원가 상승을 고려하여 2.0중량% 이하로 첨가하되 0.25중량%로 첨가하는 것이 바람직하다.Since the recommended daily intake of nattokinase is 100-200 mg per day, it is necessary to add 0.125-0.25% by weight based on 80 g of the reproductive type tea composition (40 g once a day). Since it is synergistic effect according to the ingestion is added at least 0.05% by weight, but in consideration of the increase in cost is added at 2.0% by weight or less, preferably added at 0.25% by weight.
한편, 본 발명의 주요 조성물인 발아 현미란 현미를 싹틔운 것으로 발아 과정 중 전에 없던 특이한 약효 성분들이 새로 생겨나거나 현저히 증가하게 되어, 아라비녹시란, 감마오리자놀, 클로로피린, SOD, 활성화된 섬유소, 비타민류, 미네랄류 등이 새로 생겨나거나 증가됨으로 쾌변, 에너지 대사 촉진, 비만, 혈액 순환, 자연 치유력 증진 등의 효능이 있는 것으로 알려졌다.Meanwhile, germinated brown rice, which is the main composition of the present invention, sprouts brown rice, and new and unusually active ingredients that were not present during the germination process are newly formed or increased significantly, such as arabinoxylan, gamma-orizanol, chloropyrin, SOD, activated fiber, It is known that vitamins and minerals are newly formed or increased, such as eccentricity, energy metabolism promotion, obesity, blood circulation, and natural healing.
따라서 본 발명에서는 발아 현미를 66.2중량% 이상 첨가하여 그 효능을 충분히 이용하도록 하였으나 다른 조성물과의 맛의 조화를 고려하여 84.5중량% 이하로 첨가하는 것이 바람직하며, 특히 80.43중량%로 첨가하는 것이 가장 바람직하다.Therefore, in the present invention, 66.2% by weight or more of germinated brown rice is added to fully utilize the efficacy, but it is preferable to add 84.5% by weight or less in consideration of the balance of taste with other compositions, in particular, 80.43% by weight desirable.
발아 보리 또한 보리를 싹틔운 것으로서 섬유질, 칼슘, 철분, 비타민 B군 등이 함유되어 있어 설사, 당뇨, 피부, 변비, 혈액 순환 불량 등에 효능이 있어 1.0중량% 이상으로 첨가하되 10.0중량%를 초과할 경우 보리 섬유질 특유의 점성이 너무 강해지므로 상기 범위 내로 첨가하는 것이 바람직하며, 특히 5.0중량%로 첨가하는 것이 가장 바람직하다.Germinated barley is also sprouting barley and contains fiber, calcium, iron, vitamin B group, etc. It is effective in diarrhea, diabetes, skin, constipation, poor circulation, etc. In this case, since the viscosity peculiar to the barley fiber becomes too strong, it is preferable to add it within the above range, and it is particularly preferable to add it at 5.0% by weight.
발아 수수에는 탄수화물, 단백질, 지방, 비타민 B군, 미네랄, 섬유소 등이 함유되어 있으며 심혈관계 및 소화 촉진, 약물 해독 등에 좋은 장점이 있다. 이 또한 0.1중량% 이하로 첨가할 경우 그 효능의 발현이 미약하므로 0.1중량% 이상 첨가하지만 전체 조성물의 조화를 고려하여 0.7중량% 이하로 첨가하는 것이 바람직하며, 0.4중량%로 첨가하는 것이 가장 바람직하다.Germinated sorghum contains carbohydrates, proteins, fats, B vitamins, minerals, and fiber, and has good benefits in cardiovascular and digestion and drug detoxification. In addition, when added at 0.1% by weight or less, since the expression of its efficacy is weak, it is added at 0.1% by weight or more, but in consideration of the harmony of the whole composition, it is preferable to add it at 0.7% by weight or less, and most preferably, 0.4% by weight. Do.
발아 율무는 다른 곡류에 비하여 단백질과 지방이 조금 많은 것이 특징인데 탄수화물은 대부분 찰기가 있는 녹말로 구성되어 있다. 이외에도 지방, 비타민 B1, B2, 칼슘, 철분 등이 함유되어 있어 당뇨, 고혈압, 이뇨, 체중 조절, 신경통 등에 효과가 있는 것으로 알려져 있다. 발아 율무 역시 최소한의 영양적 효과를 고려하여 0.1중량% 이상으로 첨가하되 이것 역시 가격 상승의 경제적 측면을 고려하여 0.7중량% 이하로 첨가하는 것이 바람직하며, 0.4중량%로 첨가하는 것이 가장 바람직하다.Germination rate is slightly higher in protein and fat than other grains. Most carbohydrates are made of cold starch. In addition, it contains fat, vitamin B 1 , B 2 , calcium, iron, etc. It is known to be effective in diabetes, hypertension, diuresis, weight control, neuralgia. Germination rate is also added in more than 0.1% by weight in consideration of the minimum nutritional effect, but also in consideration of the economic aspect of the price increase is preferably added in less than 0.7% by weight, most preferably in 0.4% by weight.
발아 검정콩은 단백질, 아미노산, 필수지방산, 레시틴, 비타민 A, B1, B2, 니아신, 미네랄 등이 함유되어 있으며 관절염, 신장병, 위장병, 변비, 이뇨, 불면증 등에 효과가 있다. 따라서 최소한의 효과를 나타낼 수 있는 0.2중량% 이상으로 첨가하되 가격 상승의 측면을 고려하여 0.8중량% 이하로 첨가하는 것이 바람직하며, 그 중 0.5중량%로 첨가하는 것이 가장 바람직하다.Germinated black soybeans contain protein, amino acids, essential fatty acids, lecithin, vitamins A, B 1 , B 2 , niacin, and minerals, and are effective in arthritis, kidney disease, gastrointestinal diseases, constipation, diuresis and insomnia. Therefore, the addition of 0.2% by weight or more that can exhibit a minimum effect is preferred to add to 0.8% by weight or less in consideration of the side of the price increase, of which 0.5% by weight is most preferred.
발아 검정깨에는 단백질, 지방, 비타민 A, 비타민 C, 칼슘, 인, 철 등이 함유되어 있어 당뇨병, 신장병, 노이로제, 허약자, 간장병, 결핵 등에 효과가 있는 것으로 알려져 있는데, 0.3중량% 이하로 첨가할 경우 그 효능이 미약하고 0.8중량% 이상 첨가하면 가격이 비싸지므로 상기 범위 내로 첨가하는 것이 바람직하며 특히 0.5중량%로 첨가하는 것이 가장 바람직하다.Germinated black sesame seeds contain protein, fat, vitamin A, vitamin C, calcium, phosphorus and iron, which are known to be effective for diabetes, kidney disease, neurosis, weakness, liver disease and tuberculosis. In this case, the efficacy is weak and the addition of more than 0.8% by weight is expensive, it is preferable to add within the above range, and most preferably added at 0.5% by weight.
발아 옥수수는 탄수화물, 지방산, 레시틴, 트레오닌 등이 주요 함유 성분으로 이뇨, 신장병, 당뇨, 방광염 등에 효과가 있어 2.5중량% 이상 첨가하되 5.0중량% 이상으로 첨가할 경우 가격이 비싸지므로 상기 범위내로 첨가하는 것이 바람직하며, 3.0중량%로 첨가하는 것이 가장 바람직하다.Germinated corn is a carbohydrate, fatty acid, lecithin, threonine, etc. are the main ingredients of diuretics, kidney disease, diabetes, cystitis, etc. It is effective to add more than 2.5% by weight, but if added in more than 5.0% by weight it is added within the above range Preference is given to adding, most preferably at 3.0% by weight.
발아 차조에는 주로 전분, 환원당 등의 탄수화물과 단백질, 지방, 비타민 B군 및 칼슘, 철 등이 주로 함유되어 있고 당뇨병, 빈뇨, 산후회복, 어린이 발육 촉진 등에 특히 이로운데, 1.0중량%보다 적을 경우 효능이 미약하고 또한 이것 역시 4.0중량% 이상으로 첨가하게 되면 가격 상승이 초래되므로 1.0중량%∼4.0중량%의 범위 내로 첨가하는 것이 바람직하며 특히 2.5중량%로 첨가하는 것이 가장 바람직하다.Germination tea mainly contains carbohydrates such as starch and reducing sugar, and protein, fat, vitamin B group, calcium and iron, and is particularly beneficial for diabetes, urinary frequency, postpartum recovery, and children's development. This feeble addition and addition of more than 4.0% by weight also leads to an increase in price, so it is preferable to add it within the range of 1.0% by weight to 4.0% by weight, most preferably 2.5% by weight.
발아 팥은 사포닌, 콜린, 지방산, 비타민 B1, 섬유질 등이 주요 함유 성분으로서 신장병, 위장병, 에너지 대사 촉진, 숙취 해독, 변비 등에 좋은 효과가 있다. 특히 혈소판 응집을 억제하는 기능이 있어 혈전 형성을 예방할 수 있다. 따라서 전체적인 조성물의 첨가량 및 향미의 조화를 고려하여 1.0중량%∼10.0중량%의 범위로 첨가하는 것이 바람직하며 그 중 5.0중량%로 첨가하는 것이 가장 바람직하다.Germinated red beans are saponin, choline, fatty acids, vitamin B 1 , fiber, etc. The main components are kidney disease, gastrointestinal disease, energy metabolism promotion, hangover detoxification, constipation and so on. In particular, it has a function of inhibiting platelet aggregation, thereby preventing thrombus formation. Therefore, it is preferable to add in the range of 1.0% by weight to 10.0% by weight, and most preferably, 5.0% by weight in consideration of the addition of the overall composition and the balance of the flavor.
표고버섯에는 탄수화물, 단백질, 지방, 비타민, 칼륨, 칼슘, 인, 철 등이 함유되어 있으며 항암, 고혈압, 심장병, 당뇨, 뇌졸중, 뇌신경 강화 등의 효능이 있으므로 첨가하는 것이 바람직하다.Shiitake mushrooms contain carbohydrates, proteins, fats, vitamins, potassium, calcium, phosphorus, iron, etc., and it is preferable to add them because they are effective in anticancer, hypertension, heart disease, diabetes, stroke, and nerve strengthening.
케일은 탄수화물, 단백질, 비타민류, 칼슘, 철, 엽록소 등이 함유되어 있고 항암, 동맥경화, 간장병, 위장, 비만, 신장병, 빈혈 등에 효능이 있으므로 첨가하는 것이 바람직하다.Kale contains carbohydrates, proteins, vitamins, calcium, iron, chlorophyll, and the like, and is effective in anticancer, arteriosclerosis, liver disease, gastrointestinal, obesity, kidney disease, and anemia.
다시마에는 비타민류, 칼륨, 칼슘, 철, 요오드 등이 함유되어 있고 고혈압, 신장병, 동맥 경화, 당뇨, 위궤양, 심장병, 변비, 류마티스, 악성빈혈 등에 효능이 있으므로 첨가하는 것이 바람직하다.The kelp contains vitamins, potassium, calcium, iron, iodine and the like, and is effective in hypertension, kidney disease, atherosclerosis, diabetes, gastric ulcer, heart disease, constipation, rheumatism, pernicious anemia, and so on.
김은 비타민 A, B1, B2, C, K와 칼슘, 인 등이 주요 함유 성분으로 위, 십이지장 궤양, 식욕부진, 간장병, 고혈압 등에 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed is a vitamin A, B 1 , B 2 , C, K and calcium, phosphorus, etc. are the main ingredients are effective in stomach, duodenal ulcers, anorexia, liver disease, high blood pressure, etc. It is preferable to add.
미역은 단백질, 비타민 A, B1, B2, C, K와 칼슘, 인, 철 등이 함유되어 있고 변비, 비만, 신진대사 촉진, 조혈 작용의 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed contains protein, vitamins A, B 1 , B 2 , C, K and calcium, phosphorus, iron, etc., and it is preferable to add constipation, obesity, metabolism promotion, hematopoietic effect.
쑥에는 비타민 A, K, C와 치네올이 함유되어 있어 해열, 진통, 해독, 구충, 혈압강하 등에 효능이 있으므로 첨가하는 것이 바람직하다.Mugwort contains vitamins A, K, C and cineol, so it is effective in antipyretic, analgesic, detoxification, hookworm, lowering blood pressure and so on.
솔잎은 비타민 A, K, C와 철분, 효소 등이 주로 함유되어 있으며 고혈압, 저혈압, 빈혈, 조혈, 정혈작용, 강장, 콜레스테롤 저하에 효능이 있으므로 첨가하는 것이 바람직하다.Pine needles contain vitamins A, K, C and iron, enzymes, etc., and high blood pressure, hypotension, anemia, hematopoiesis, antistatic action, tonic, cholesterol-lowering is preferable to add.
효모에는 아미노산, 미네랄, 비타민 등이 함유되어 있으며 빈혈, 소화촉진, 아미노산 공급 등의 역할을 하므로 첨가하는 것이 바람직하다.Yeast contains amino acids, minerals, vitamins, and the like, so it is preferable to add anemia, promote digestion, and supply amino acids.
당근은 탄수화물, 단백질, 비타민류, 칼륨, 칼슘, 인, 철 등이 함유되어 있어 심장병, 저혈압, 신장병, 설사, 소화불량, 식욕부진, 치질, 대장염, 천식 등에 효능이 있으므로 첨가하는 것이 바람직하다.Carrots contain carbohydrates, proteins, vitamins, potassium, calcium, phosphorus, iron and the like, so they are effective for heart disease, hypotension, kidney disease, diarrhea, indigestion, anorexia, hemorrhoids, colitis, asthma, etc.
명일엽은 비타민 B군, 플라보노이드, 루테오닌, 이소쿠엘치트린 등이 주요 함유성분으로서 고혈압, 빈혈, 당뇨, 신경통, 이뇨, 피로 회복의 효능이 있으며 팥과 마찬가지로 혈소판 응집을 억제하는 기능이 있어 혈전 형성을 예방할 수 있으므로 첨가하는 것이 바람직하다.Myeongil Leaf contains vitamin B group, flavonoids, luteonine, and isocuelchitrin, and it has the effect of restoring hypertension, anemia, diabetes, neuralgia, diuresis, and fatigue. It is preferable to add because it can prevent the formation.
상기 재료들은 영양적 균형 및 맛의 조화, 가격 상의 경제적 측면을 고려하여 그 첨가 범위를 결정하였으므로 상기 기재한 첨가 범위 이내로 첨가하는 것이 바람직하다.Since the ingredients have been determined in consideration of the nutritional balance, the harmony of taste, and the economical aspect of the price, it is preferable to add the ingredients within the above-described addition range.
또한 로얄젤리, 스테비오 사이드 등을 첨가하여 생식 타입 차 조성물의 영양과 맛을 보강할 수 있다.Royal jelly and stevioside may also be added to enhance the nutrition and taste of the raw tea composition.
본 발명에 따른 차 조성물의 정확한 1일 섭취량은 상황에 따라 다르지만 성인의 경우 40g 용량씩 1일 1∼2회 섭취하는 것이 바람직하다.The exact daily intake of the tea composition according to the present invention varies depending on the situation, but for adults it is preferred to take 40g dose once or twice a day.
이하 실시예를 통하여 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to the following Examples.
[실시예 1]Example 1
발아 현미 80.43중량%, 발아 보리 5.0중량%, 발아 수수 0.4중량%, 발아 율무 0.4중량%, 발아 검정콩 0.5중량%, 발아 검정깨 0.5중량%, 발아 옥수수 3.5중량%, 발아 차조 2.5중량%, 표고버섯 0.2중량%, 석이버섯 0.5중량%, 미강 0.5중량%, 케일 0.5중량%, 다시마 0.4중량%, 김 0.4중량%, 미역 0.4중량%, 당근 0.5중량%, 쑥 0.2중량%, 솔잎 0.3중량%, 무 0.3중량% 각각의 재료를 익히지 않고 생으로 건조하여 분말로 한 것과 홍국 1.5중량%, 나토키나제 0.25중량%, 로얄 젤리 0.3중량%, 젖산 효모 0.5중량%, 스테비오 사이드 0.02중량% 각각을 50메쉬 체로 통과시킨 후 V형혼합기에 넣고 30분간 잘 혼합하여 1회 섭취 분량인 40g으로 포장한다.Germinated brown rice 80.43 wt%, germinated barley 5.0 wt%, germinated sorghum 0.4 wt%, germination rate 0.4 wt%, germinated black soybean 0.5 wt%, germinated black sesame 0.5 wt%, germinated corn 3.5 wt%, germinated tea 2.5 wt% Mushroom 0.2 wt%, Shiitake 0.5 wt%, Rice bran 0.5 wt%, Kale 0.5 wt%, Kelp 0.4 wt%, Seaweed 0.4 wt%, Seaweed 0.4 wt%, Carrot 0.5 wt%, Mugwort 0.2 wt%, Pine needle 0.3 wt% , 0.3% by weight of radish, dried without raw materials, 1.5% by weight of red rice, 1.5% by weight of nattokinase, 0.3% by weight of royal jelly, 0.5% by weight of lactic acid yeast, and 0.02% by weight of stevioside. After passing through a sieve, put it in a V-type mixer, mix well for 30 minutes, and pack it in a 40g serving size.
[실시예 2]Example 2
발아 현미 69.63중량%, 발아 보리 5.0중량%, 발아 수수 0.4중량%, 발아 율무 0.4중량%, 발아 검정콩 0.5중량%, 발아 검정깨 0.5중량%, 발아 옥수수 3.5중량%, 발아 차조 2.5중량%, 발아 팥 5.0중량%, 표고버섯 0.2중량%, 석이버섯 0.5중량%, 미강 0.5중량%, 케일 0.5중량%, 다시마 0.4중량%, 김 0.4중량%, 미역 0.4중량%, 당근 0.5중량%, 쑥 0.2중량%, 솔잎 0.3중량%, 무 0.3중량%, 명일엽 5.0중량%, 메밀 0.5중량%, 양배추 0.3중량% 각각의 재료를 익히지 않고 생으로 건조하여 분말로 한 것과 홍국 1.5중량%, 나토키나제 0.25중량%, 로얄 젤리 0.3중량%, 젖산 효모 0.5중량%, 스테비오 사이드 0.02중량% 각각을 50메쉬 체로 통과시킨 후 V형 혼합기에 넣고 30분간 잘 혼합하여 1회 섭취 분량인 40g으로 포장한다.Germinated brown rice 69.63 wt%, germinated barley 5.0 wt%, germinated sorghum 0.4 wt%, germination rate 0.4 wt%, germinated black soybean 0.5 wt%, germinated black sesame 0.5 wt%, germinated corn 3.5 wt%, germinated tea 2.5 wt%, germination Red beans 5.0%, Shiitake 0.2%, Shiitake 0.5%, Rice bran 0.5%, Kale 0.5%, Seaweed 0.4%, Seaweed 0.4%, Seaweed 0.4%, Carrot 0.5%, Mugwort 0.2% %, Pine needles 0.3%, radish 0.3%, radish 5.0%, buckwheat 0.5%, cabbage 0.3% by weight, dried without raw material, 1.5% by weight of red rice soup, 0.25% by weight of nattokinase, 0.3% by weight of royal jelly, 0.5% by weight of lactic acid yeast, and 0.02% by weight of stevioside are passed through a 50-mesh sieve, and then put into a V-type mixer, mixed well for 30 minutes, and packaged as 40 g of a single intake.
[실시예 3]Example 3
발아 현미 77.18중량%, 홍국 3.0중량%, 나토키나제 2.0중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that the germinated brown rice was added in 77.18% by weight, red rice soup 3.0% by weight, nattokinase 2.0% by weight.
[비교예 1]Comparative Example 1
발아 현미를 82.18중량%로 첨가하고 홍국, 나토키나제를 첨가하지 않은 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that the germinated brown rice was added at 82.18% by weight and no red yeast or nattokinase was added.
[비교예 2]Comparative Example 2
발아 현미 78.63중량%, 홍국 3.3중량%, 나토키나제 0.25중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 78.63 wt% of germinated brown rice, 3.3 wt% of red yeast rice, and 0.25 wt% of nattokinase were added.
[비교예 3]Comparative Example 3
발아 현미 78.58중량%, 홍국 1.5중량%, 나토키나제 2.1중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 78.58 wt% of germinated brown rice, 1.5 wt% of red yeast rice, and 2.1 wt% of nattokinase were added.
[관능 검사][Sensory test]
훈련된 패널 15인에 의해 5점 척도법으로 관능 검사를 실시하여 그 결과를 아래의 표 2에 나타내었다.The sensory test was carried out on a 5-point scale by 15 trained panelists. The results are shown in Table 2 below.
홍국의 다량 첨가는 색깔이 붉은 관계로 식감을 떨어뜨려 맛의 항목에서 낮은 점수가 나왔으며 나토키나제를 다량 첨가한 경우도 전체 기호도를 감소시켰다.The addition of large amounts of red yeast rice resulted in a lower score in the category of taste due to the red color, and the addition of large amounts of nattokinase decreased overall preference.
실시예 1, 2, 3은 맛과 향 및 전체 기호도 모두 홍국과 나토키나제를 첨가하지 않은 비교예 1보다 우수한 것으로 나타나 홍국 및 나토키나제의 첨가는 영양적 측면의 보강 뿐만 아니라 기호도도 향상시키는 것을 확인할 수 있었고, 실시예 1이 최적 실시예임을 확인할 수 있었다.Examples 1, 2, and 3 show that the taste, aroma, and overall taste are superior to Comparative Example 1 without adding red yeast and nattokinase, so that the addition of red yeast and nattokinase improves not only the nutritional aspect but also the palatability. It was able to confirm that Example 1 is the optimal embodiment.
따라서 본 발명에 따른 생식 타입의 차 조성물은 기존의 생식 타입 차 조성물보다 영양적 측면 및 기호도에서 더욱 우수한 제품임을 확인할 수 있었다.Therefore, it was confirmed that the reproductive type tea composition according to the present invention is better in nutritional aspects and preferences than the conventional reproductive type tea composition.
상기한 바와 같이 이루어지는 본 발명에 의하면, 생식 타입의 차 조성물에 콜레스테롤 증가의 80%의 원인이 되는 간장에서 합성되는 콜레스테롤을 억제하는 기능을 가진 홍국과 혈전 용해 효소인 나토키나제 그리고 혈전 형성의 시초인 혈소판 응집을 억제하는 기능이 있는 팥과 명일엽을 첨가함으로써, 이미 생성된 혈전을 용해시켜 제거하는 성분들의 상승 작용으로 콜레스테롤 및 혈전 저하 기능이 강화된 생식 타입의 차 조성물을 제공할 수 있다.According to the present invention made as described above, red tea with a function of inhibiting cholesterol synthesized in the liver that causes 80% of cholesterol increase in the reproductive type tea composition, nattokinase which is a thrombolytic enzyme, and the beginning of thrombus formation By adding adzuki bean and Myeong-il leaf, which have a function of inhibiting platelet aggregation, synergistic action of components that dissolve and remove already formed thrombi can provide a reproductive type tea composition with enhanced cholesterol and thrombus lowering function.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000070027A KR100337005B1 (en) | 2000-11-23 | 2000-11-23 | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000070027A KR100337005B1 (en) | 2000-11-23 | 2000-11-23 | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010074008A KR20010074008A (en) | 2001-08-04 |
KR100337005B1 true KR100337005B1 (en) | 2002-05-17 |
Family
ID=19700938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000070027A KR100337005B1 (en) | 2000-11-23 | 2000-11-23 | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100337005B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101094733B1 (en) * | 2009-01-12 | 2011-12-16 | 조아제약주식회사 | Composition for improving adultdisease or anti-aging comprising natokinase and royal jelly |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020093147A (en) * | 2002-05-30 | 2002-12-13 | 지니스생명공학 주식회사 | Preventive and Dietary Supplement for adult chronic disease |
KR20110138001A (en) * | 2010-06-18 | 2011-12-26 | (주)아모레퍼시픽 | Composition comprising colored-bean extracts |
KR20110138000A (en) * | 2010-06-18 | 2011-12-26 | (주)아모레퍼시픽 | Composition comprising colored-bean extracts |
KR101866327B1 (en) * | 2016-09-26 | 2018-06-11 | 농업회사법인 하늘빛 주식회사 | Vegetable tea drinks |
-
2000
- 2000-11-23 KR KR1020000070027A patent/KR100337005B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101094733B1 (en) * | 2009-01-12 | 2011-12-16 | 조아제약주식회사 | Composition for improving adultdisease or anti-aging comprising natokinase and royal jelly |
Also Published As
Publication number | Publication date |
---|---|
KR20010074008A (en) | 2001-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
CN101766274B (en) | Antioxidant functional food composition containing bamboo-leaves flavones | |
KR102062989B1 (en) | Method for producing vinegar jelly for diet using healthful food powder | |
KR20130001560A (en) | Process for preparing yacon pickle | |
KR100336644B1 (en) | The composites of raw-type tea with anti-obese function | |
KR100337005B1 (en) | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi | |
CN108244654A (en) | Caterpillar fungus nutritire breakfast flour | |
KR101622767B1 (en) | Method for Manufacturing Sauce for spiced rib Using dietary Fiber | |
KR100329011B1 (en) | The composites of raw-type tea containing octacosanol | |
KR20210035592A (en) | galeusinialeul iyonghan biman haeso gineung-ui saengsigtaib cha joseongmul | |
CN103461415B (en) | Mud snail bread and processing method thereof | |
KR100325584B1 (en) | The composites of raw-type tea with anti-diabetic function | |
KR100336650B1 (en) | The composites of raw-type tea with the function of activating the brain and promoting the growth | |
KR20190140737A (en) | Vinegar compositions comprising detox-diet material and manufacturing method thereof | |
KR100336646B1 (en) | The composites of raw-type tea containing arabinoxylane | |
KR102085713B1 (en) | Method for producing vinegar foaming tablet for diet | |
KR100390095B1 (en) | Preparation method of gimchi with aloe gel | |
KR100329010B1 (en) | The composites of raw-type tea containing propolis extract powder | |
CN101659919B (en) | Multi-vitamin fruit vinegar and preparing method thereof | |
CN102499375A (en) | Preparation method for health-care food | |
KR20010025273A (en) | Functional beverage using non-flavored Chungkookjang | |
CN102533520A (en) | Grain and persimmon aromatic vinegar and preparation method thereof | |
KR100336645B1 (en) | The composites of raw-type tea containing chitosan | |
KR20220166894A (en) | Components of reproductive tea that enhance brain activation and growth promotion | |
KR20020086372A (en) | Composition for suppressing hyperlipidemia containing grains, fruits and vegetables, seeweeds and mushrooms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G15R | Request for early opening | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20110503 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |